Colombia - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Colombia Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 3.8% year on year. In 2019, the country was number 102 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 225 Cases. Colombia is overtaken by Guinea, which was number 101 at 231 Cases and is followed by Tanzania at 224 Cases. India topped the ranking with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 225.00 |
| 2018 | 205.00 |
| 2017 | 198.00 |
| 2016 | 181.00 |
| 2015 | 194.00 |
How does Colombia rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 99 |
#99
Morocco
|
235 | 2019 | -18.1 % | +15.4 % | View data | |
| 102 |
#102
Colombia
|
225 | 2019 | +9.8 % | +3.8 % | View data | |
| 104 |
#104
Argentina
|
222 | 2019 | +27.6 % | +14.3 % | View data | |